---
title: Adderall Vyvanse and Ritalin mechanisms
videoId: sxgCC4H1dl8
---

From: [[hubermanlab]] <br/> 
In this article, we will explore how three commonly prescribed medications for Attention Deficit Hyperactivity Disorder (ADHD)—[[stimulants_for_adhd_treatment | Adderall]], Vyvanse, and Ritalin—work at the neurobiological level. This exploration is grounded in the insights provided by Dr. Andrew Huberman in his detailed discussion on the Huberman Lab podcast. Each of these medications belongs to a category of drugs known as stimulants or sympathomimetics, which function primarily by altering the levels of specific neurotransmitters in the brain.

## Adderall: Dual Salt Amphetamine

Adderall is composed of a 3:1 ratio of two amphetamine salts, D-amphetamine (dextroamphetamine) and L-amphetamine (levoamphetamine). This combination effectively increases the levels of two critical neuromodulators, dopamine and norepinephrine, primarily by inhibiting their reuptake and promoting their release in the brain <a class="yt-timestamp" data-t="00:21:00">[00:21:00]</a>.

- **D-amphetamine** is more potent in increasing dopamine and engages primarily with the central nervous system, enhancing [[understanding_dopamines_role_in_motivation_and_satisfaction | focus and motivation]].
- **L-amphetamine**, while less potent at increasing dopamine, has more pronounced peripheral effects, such as increasing heart rate and blood pressure <a class="yt-timestamp" data-t="00:22:00">[00:22:00]</a>.

**Mechanism**: Adderall disrupts dopamine and norepinephrine transporters that normally reabsorb these neurotransmitters into neurons, allowing higher concentrations to enhance signal transmission across synapses <a class="yt-timestamp" data-t="00:27:51">[00:27:51]</a>.

## Vyvanse: A Time-Release Dextroamphetamine

Vyvanse (lisdexamfetamine) differentiates itself by being a [[tools_for_improving_focus_and_attention | prodrug]]. It consists of D-amphetamine bound to the amino acid lysine, which is metabolized in the body into active D-amphetamine <a class="yt-timestamp" data-t="00:33:04">[00:33:04]</a>. The release mechanism leads to a gradual increase in dopamine and norepinephrine levels over a longer period.

**Mechanism**: Once ingested, Vyvanse ensures a continuous and stable release of D-amphetamine into the system, thereby reducing the risk of high, rapid spikes in dopamine and potential abuse <a class="yt-timestamp" data-t="00:33:50">[00:33:50]</a>.

> [!info] Long-Lasting Effects
> 
> The timed release of Vyvanse can extend the drug's efficacy for between 12 to 16 hours, supporting more sustained attention with a lower risk of dependency compared to immediate-release formulas.

## Ritalin: The Non-Amphetamine Stimulant

Ritalin, or Methylphenidate, operates differently from amphetamines by primarily acting as a norepinephrine-dopamine reuptake inhibitor. Although chemically different from amphetamines, its function at the synapse is somewhat similar in altering neurotransmitter concentrations <a class="yt-timestamp" data-t="00:37:55">[00:37:55]</a>.

**Mechanism**: Ritalin inhibits the reuptake of dopamine and norepinephrine back into the neurons, leading to an increased concentration of these chemicals in the synaptic cleft and a corresponding improvement in attention and decrease in hyperactivity <a class="yt-timestamp" data-t="00:38:55">[00:38:55]</a>.

**Unique Attributes**: Unlike Adderall and Vyvanse, Ritalin tends to have a shorter half-life, generally requiring more frequent dosing. This short-action profile can be advantageous for managing specific dosing schedules, especially concerning sleep-related side effects <a class="yt-timestamp" data-t="00:39:30">[00:39:30]</a>.

## Conclusion

All three medications serve a critical role in managing ADHD symptoms by modulating the dopaminergic and noradrenergic systems in the brain. Despite their shared goal, the distinct mechanisms by which Adderall, Vyvanse, and Ritalin operate provide healthcare providers with a range of options to tailor treatment to individual patient needs, thereby maximizing therapeutic benefits and minimizing adverse effects. Understanding these differences can help inform discussions between patients and healthcare providers to determine the most appropriate treatment strategy [[understanding_adhd_and_focus]].